Pharma ETFs Could Flatline on Obamacare Bust
November 20, 2013 at 14:19 PM EST
The health care industry, along with related exchange traded funds, was salivating at the untapped revenue President Obama’s Affordable Care Act would bring in, but potential enrollment problems could lead to a 30% cut in U.S. pharma sales projections. According to the IMS Institute, U.S....